PodParley PodParley

#10: Cuts, commensals, and chemokines

An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#10: Cuts, commensals, and chemokines" was published on June 28, 2021 and runs 17 minutes.

June 28, 2021 ·17m · Inflammatory Content

0:00 / 0:00

Getting physically injured is no fun—it can often take long periods of time to recover. What if we could accelerate the wound healing process? Here, Kellen dissects an original article, titled “The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin”, that reveals mechanisms underlying skin injury and identifies novel therapeutic approaches to speed up healing. The report was written by Jeremy Di Domizio et al. and was published in Nature Immunology in July of 2020.Paper: https://www.nature.com/articles/s41590-020-0721-6Commentary: https://www.nature.com/articles/s41590-020-0755-9?proof=tTo help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero). Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.

Getting physically injured is no fun—it can often take long periods of time to recover. What if we could accelerate the wound healing process? Here, Kellen dissects an original article, titled “The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin”, that reveals mechanisms underlying skin injury and identifies novel therapeutic approaches to speed up healing. The report was written by Jeremy Di Domizio et al. and was published in Nature Immunology in July of 2020.

Paper: https://www.nature.com/articles/s41590-020-0721-6

Commentary: https://www.nature.com/articles/s41590-020-0755-9?proof=t

To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero).

Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.

Praat erover: leven met een chronische ziekte AbbVie Belgium & Luxembourg Leren leven met een chronische ziekte, dat betekent dat je leven fundamenteel verandert. Het betekent een kruis door bepaalde activiteiten. Het is een uitdaging, elke dag. De patiënten die getuigen in deze podcast leven met een reumatische ontstekingsziekte. Ze doen er alles aan om het beste leven te leiden dat mogelijk is, ondanks hun ziekte. Alles, om het doel te bereiken dat ‘remissie’ heet. Alles om een normaal leven te leiden, simpel gezegd. Ze leggen uit hoe hun ziekte hun leven verandert, en hoe ze de dagelijkse beproevingen doorstaan. Ze vertellen over hun diepste wensen en hun hoop voor de toekomst.*Het vierde seizoen van "Praat erover" gaat over migraine.*Het derde seizoen van "Praat erover" gaat over psoriasis. *Het tweede seizoen van "Praat erover" richt zich op inflammatoire darmziekte (IBD), de ziekte van Crohn en colitis ulcerosa.*Het eerste seizoen van "Praat erover" gaat over inflammatoire reumatische aandoeningen.  Voor meer informatie :www.abbvie.be (http://ww Nebraska Food for Health Center The multidisciplinary Nebraska Food for Health Center brings together strengths in agriculture and medicine from throughout the University of Nebraska system. We help develop hybrid crops and foods to improve the quality of life of those affected by critical diseases including heart disease, diabetes, obesity, cancers, inflammatory bowel disease and mental disorders. Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease AOSD Podcast Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease. Talk IBC Terry Arnold Talk IBC is where we discuss things related to inflammatory breast cancer, from patient's personal stories to the latest in research. This podcast is sponsored by The IBC Network Foundation.
URL copied to clipboard!